{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:44:26Z","timestamp":1773330266584,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"DOI":"10.1007\/s11934-026-01326-3","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:35:30Z","timestamp":1773282930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Lower Urinary Tract Symptoms in Patients on Active Surveillance for Prostate Cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Jada","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6348-8857","authenticated-orcid":false,"given":"Felix","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"1","key":"1326_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. J Urol. 2022;208(1):10\u20138.","journal-title":"J Urol"},{"key":"1326_CR2","unstructured":"JiangDDSJ, Chakiryan N, Gillis K, Liu M, Newcomb L, Zheng Y, Chang P, Wagner AA. Lower urinary tract symptoms in patients with prostate cancer on active surveillance. NEAUA 2021. https:\/\/meeting.neaua.org\/abstracts\/2021\/P26.cgi"},{"issue":"6","key":"1326_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5152\/tud.2021.21262","volume":"47","author":"MA \u0130bis","year":"2021","unstructured":"\u0130bis MA, Cayan S, Tokatli Z, Orhan \u0130, Asc\u0131 R, Kocamanoglu F, et al. Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study. Turk J Urol. 2021;47(6):501\u20138.","journal-title":"Turk J Urol"},{"issue":"1","key":"1326_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.urology.2013.05.070","volume":"83","author":"AS Glass","year":"2014","unstructured":"Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR. Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort. Urology. 2014;83(1):33\u20138.","journal-title":"Urology"},{"issue":"6","key":"1326_CR5","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1016\/j.juro.2009.08.044","volume":"182","author":"K Fujita","year":"2009","unstructured":"Fujita K, Landis P, McNeil BK, Pavlovich CP. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol. 2009;182(6):2664\u20139.","journal-title":"J Urol"},{"issue":"6","key":"1326_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876\u201392.","journal-title":"Eur Urol"},{"issue":"1","key":"1326_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023. J Urol. 2024;211(1):11\u20139.","journal-title":"J Urol"},{"issue":"3","key":"1326_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.eururo.2014.11.006","volume":"68","author":"L Cindolo","year":"2015","unstructured":"Cindolo L, Pirozzi L, Fanizza C, Romero M, Tubaro A, Autorino R, et al. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol. 2015;68(3):418\u201325.","journal-title":"Eur Urol"},{"issue":"9","key":"1326_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJM199802263380901","volume":"338","author":"JD McConnell","year":"1998","unstructured":"McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998;338(9):557\u201363.","journal-title":"N Engl J Med"},{"issue":"13","key":"1326_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","volume":"362","author":"GL Andriole","year":"2010","unstructured":"Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362(13):1192\u2013202.","journal-title":"N Engl J Med"},{"issue":"3","key":"1326_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa030660","volume":"349","author":"IM Thompson","year":"2003","unstructured":"Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215\u201324.","journal-title":"N Engl J Med"},{"issue":"4","key":"1326_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/JU.0000000000002183","volume":"206","author":"LB Lerner","year":"2021","unstructured":"Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol. 2021;206(4):806\u201317.","journal-title":"J Urol"},{"issue":"4","key":"1326_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.juro.2008.06.079","volume":"180","author":"CG Roehrborn","year":"2008","unstructured":"Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L. Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study. J Urol. 2008;180(4):1228\u201334.","journal-title":"J Urol"},{"issue":"1","key":"1326_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003985","volume":"212","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, et al. The AUA\/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder. J Urol. 2024;212(1):11\u201320.","journal-title":"J Urol"},{"issue":"4","key":"1326_CR15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/JU.0000000000003156","volume":"209","author":"E BenidirT, Austhof","year":"2023","unstructured":"BenidirT, Austhof E, Ward RD, et al. Impact of prostate urethral lift device on prostate magnetic resonance image quality. J Urol. 2023;209(4):752\u201361. https:\/\/doi.org\/10.1097\/JU.0000000000003156","journal-title":"J Urol"},{"issue":"11","key":"1326_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/pros.24906","volume":"85","author":"C B\u00e2cle","year":"2025","unstructured":"B\u00e2cle C, Seizilles De Mazancourt E, Abid N, Ruffion A, Rouvi\u00e8re O, Colombel M, et al. Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms. Prostate. 2025;85(11):989\u201399.","journal-title":"Prostate"},{"issue":"6","key":"1326_CR17","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","volume":"67","author":"J-N Cornu","year":"2015","unstructured":"Cornu J-N, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. Eur Urol. 2015;67(6):1066\u201396.","journal-title":"Eur Urol"},{"issue":"4 Suppl 1","key":"1326_CR18","first-page":"13","volume":"26","author":"AK Das","year":"2019","unstructured":"Das AK, Teplitsky S, Humphreys MR. Holmium laser enucleation of the prostate (HoLEP): a review and update. Can J Urol. 2019;26(4 Suppl 1):13\u20139.","journal-title":"Can J Urol"},{"issue":"5","key":"1326_CR19","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","volume":"199","author":"P Gilling","year":"2018","unstructured":"Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation(\u00ae) vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol. 2018;199(5):1252\u201361.","journal-title":"J Urol"},{"issue":"1","key":"1326_CR20","first-page":"10960","volume":"29","author":"PJ Gilling","year":"2022","unstructured":"Gilling PJ, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol. 2022;29(1):10960\u20138.","journal-title":"Can J Urol"},{"issue":"1","key":"1326_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.eururo.2015.07.054","volume":"69","author":"JA Thomas","year":"2016","unstructured":"Thomas JA, Tubaro A, Barber N, d\u2019Ancona F, Muir G, Witzsch U, et al. A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol. 2016;69(1):94\u2013102.","journal-title":"Eur Urol"},{"issue":"2","key":"1326_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.juro.2014.09.001","volume":"193","author":"A Bachmann","year":"2015","unstructured":"Bachmann A, Tubaro A, Barber N, d\u2019Ancona F, Muir G, Witzsch U, et al. A European multicenter randomized noninferiority trial comparing 180\u00a0W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015;193(2):570\u20138.","journal-title":"J Urol"},{"key":"1326_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.urology.2021.01.040","volume":"156","author":"G Jibara","year":"2021","unstructured":"Jibara G, Sjoberg DD, Stearns GL, Stabholz Y, Fathollahi A, Leddy LS, et al. Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance. Urology. 2021;156:225\u201330.","journal-title":"Urology"},{"issue":"9","key":"1326_CR24","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/j.1464-410X.2011.10113.x","volume":"108","author":"NP Gupta","year":"2011","unstructured":"Gupta NP, Singh P, Nayyar R. Outcomes of robot-assisted radical prostatectomy in men with previous transurethral resection of prostate. BJU Int. 2011;108(9):1501\u20135.","journal-title":"BJU Int"},{"issue":"4","key":"1326_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s11701-023-01588-w","volume":"17","author":"L Gu","year":"2023","unstructured":"Gu L, Li Y, Li X, Liu W. Does previous transurethral resection of the prostate negatively influence subsequent robotic-assisted radical prostatectomy in men diagnosed with prostate cancer? A systematic review and meta-analysis. J Robot Surg. 2023;17(4):1299\u2013307.","journal-title":"J Robot Surg"},{"key":"1326_CR26","doi-asserted-by":"crossref","unstructured":"Pompe RS, Leyh-Bannurah S-R, Preisser F, Salomon G, Graefen M, Huland H et al. Radical prostatectomy after previous TUR-P: oncological, surgical, and functional outcomes. Urol Oncol. 2018;36(12):527.e21-.e28.","DOI":"10.1016\/j.urolonc.2018.08.010"},{"key":"1326_CR27","doi-asserted-by":"crossref","unstructured":"Jaber AR, Moschovas MC, Noel J, Stirt D, Rogers T, Saikali S, et al. Does previous transurethral resection of the prostate affect the outcomes in robotic assisted radical prostatectomy? World J Urol. 2024;42(1):384.","DOI":"10.1007\/s00345-024-05105-y"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-026-01326-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:35:32Z","timestamp":1773282932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-026-01326-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1007\/s11934-026-01326-3","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Author Jada Kapoor, MBBS BMedSc has nothing to disclose. Author Felix Cheung, MD owns stock in Procept BioRobotics that manufactures device for robotic waterjet therapy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"17"}}